Due to recent developments, shares of several businesses will be the focus of attention when trading resumes on Monday. Adani Enterprises, Sun Pharma, NTPC, Bajaj Finance, Vedanta, and others are among these.
In Short
- Adani Enterprises denies damage to Haifa Port, calms investor fears
- Bajaj Finance shares to trade ex-bonus and ex-stock split from June 17
- NTPC starts commercial operations at 660 MW unit in North Karanpura project
As global investors closely monitor the ongoing geopolitical tensions in the Middle East, it is anticipated that stock markets will begin the new week on a cautious note on June 16. Nervousness over rising crude oil prices and global uncertainty caused the stock market to drop by more than 1 percent the week before. Due to recent developments, shares of several businesses will be the focus of attention when trading resumes on Monday. Adani Enterprises, Sun Pharma, NTPC, Bajaj Finance, Vedanta, and others are examples of these.
ADANI ENTERPRISES
Following the clarification of reports regarding damage to Adani Enterprises’ Haifa Port in Israel, the company will be one of the most important stocks to keep an eye on. After reports that the port had been hit by an Iranian missile, the clarification came. The Adani Group’s Chief Financial Officer, Jugeshinder Robbie Singh, stated on Sunday that these reports are false. He stated that the Haifa Port has not sustained any damage and is continuing to function normally. Investors are reacting strongly to global events, particularly those pertaining to the Middle East, as a result of this statement.
SUN PHARMA
Sun Pharmaceutical has confirmed that the FDA’s Halol plant inspection was successfully completed. Eight observations were made in a Form 483 notice at the conclusion of the inspection. As they determine whether a pharmaceutical company can continue to supply medicines to the United States, one of its largest markets, such inspections are crucial. Investors will be keeping an eye on the business to see how it reacts to these observations.
BAJAJ FINANCE
Since they will begin trading on June 17 without a bonus or stock split, shares of Bajaj Finance will be in the spotlight. The company had announced a bonus issue in the ratio of 4:1, which means that for every share held, shareholders will receive four additional shares. Additionally, each share’s face value will be reduced from Rs 2 to Rs 1, making them more accessible to retail investors. During the company’s earnings report for the fourth quarter, it made announcements about these modifications.
NTPC
The state-owned power company NTPC announced that commercial operations at Unit-3 of the North Karanpura Super Thermal Power Project have begun. The capacity of this unit is 660 megawatts. The company is now able to make money from the power it generates because it started operating commercially, which could help improve its financial performance in the upcoming quarters.
ITC
ITC announced the completion of its acquisition of 100% stake in Sresta Natural Bioproducts (SNBPL) for Rs 400 crore. As a result, SNBPL and its overseas companies in the US and UAE have now become wholly owned subsidiaries of ITC.
VEDANTA
Vedanta has stated that a board meeting will be held on June 18 to discuss an interim dividend for FY26. The record date for determining which shareholders are eligible to receive the dividend has been set by the company for June 24. Before the board meeting, news of dividend proposals can have an impact on stock prices. Dividends are payments made to shareholders.
NAZARA TECHNOLOGIES
Nazara Technologies, a media and gaming company, will also be under scrutiny after well-known investor Rekha Jhunjhunwala sold more than 275,000 shares on June 13. Her stake in the company was diminished as a result of this action. The stock market typically pays attention to large stake sales made by key investors, and share prices may respond accordingly.
SYNGENE INTERNATIONAL
Syngene International, a biotech company, received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (FDA) for its GMP manufacturing facilities in Biocon Park. This report says that the FDA has finished its inspection and doesn’t have any regulatory concerns right now. As a result, investors may be interested in the stock, which is a good sign for the company.